Summary
This is a smart move for Sanofi-Aventis since Solvay has many excellent products as well as several important pipeline products.
Analysis
Sanofi-Aventis has made a smart move. Solvay has many good drugs such as Klonopin Wafer. It also has a very promising pipeline drug called biprofinox for schizophrenia. This new drug many offer advantages over the existing products in this class.
This author consults with leading institutions through GLG
Analyses are solely the work of the authors and have not been edited or endorsed by GLG.
